ARCHIVES

FDA To Once Again Review ESA Label To Reflect Results Of Negative Studies.

This article is from The Cancer Letter archive.

Vol. 33 No. 45 | December 7, 2007

Download PDF Visit The Full Archive

Related Articles

New Firm Steps Onto Texas Battleground for Control Over Office-Based Oncology

November 22, 1996

Study Validates “PEM” Scans As Biopsy Guidance Method

April 29, 2011

Three Nutrition RFPs withdrawn Due To “Vagueness”

July 8, 1977

Randomization With Options Stimulates Sedmental Accrual

February 22, 1980

Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention

October 14, 1994

RFA Announced On Model For Planning community Prevention Program

October 20, 1978